Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no single medically mandated time of day to take your first Wegovy injection, but the timing you choose on day one tends to set the rhythm for every pen that follows. Most people pick either a morning or an evening slot on a day they are at home, so any early side effects can be managed calmly rather than mid-commute. Wegovy (semaglutide) is a prescription-only medicine: a prescriber decides whether it is right for you before a single dose is taken. The practical advice below is based on NHS guidance on semaglutide and the licensed prescribing information.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Because Wegovy is injected once every seven days, the moment you choose for week one effectively locks in your schedule. If your first injection is a Thursday at 7 pm, every subsequent dose will fall on a Thursday evening. That consistency matters: gaps much shorter or longer than seven days can affect how steadily the medicine works.
The practical advice most prescribers give is to pick a day when you have a light schedule for the next 12 to 24 hours. For some people that is a Friday evening after work. For others it is a Sunday morning before the week ramps up. The key is choosing a slot you can protect reliably, not the theoretical 'ideal' time on a clock.
You can read more about what time of day works best when you start Wegovy if you want to think through the daily scheduling side, and you can read more about choosing the best day to start Wegovy if you want to think through the weekly scheduling side in more detail.
The most common side effects of semaglutide) nausea, indigestion, fatigue, tend to peak within the first day or two after each new dose or increase, then settle. Starting on a day when you can rest if needed, eat small low-fat meals, and stay well hydrated makes those early hours considerably easier to handle.
This is why an evening injection appeals to many people: any nausea during the night is less disruptive than the same feeling during a work presentation. On the other hand, some people prefer a morning start so they can stay alert to how they feel rather than waking up uncertain. Neither approach is clinically superior.
A note on food timing: unlike the oral semaglutide tablet (Wegovy tablets require a 30-minute fast before eating), the injection has no fasting requirement around the injection itself. You can give it before or after a meal.
If you are weighing up how the injection and tablet forms compare, our Wegovy treatment page sets out what is licensed in the UK.
The single biggest timing mistake our prescribers see is patients missing a weekly dose simply because the day drifted. An injection on Monday one week and Thursday the next is not a disaster (the NHS semaglutide guidance allows you to take a missed dose up to five days late) but habitual drift adds up.
Pairing the injection with something fixed in your week anchors the routine. Some people tie it to a standing weekly meeting; others keep the pen in the fridge door alongside something they reach for every Thursday morning, like the milk for their porridge. The specific pairing does not matter. The repetition does.
If you are thinking about whether to shift your day of the week once you are established, the question of which day of the week works best for Wegovy has its own considerations, particularly around social plans and any regular exercise sessions.
Timing is one piece. A few others are worth knowing before you inject for the first time.
Storage is one. Wegovy pens must be kept refrigerated at 2 to 8 degrees Celsius. The exact window for room-temperature storage before use is set out in the Patient Information Leaflet that comes with your pen, always check it rather than going by memory.
Injection site rotation is another. Abdomen, thigh and upper arm are all licensed sites; moving between them week to week reduces localised skin reactions.
Drug interactions are a third. If you take other medicines, including over-the-counter products, your prescriber should know. A question that comes up occasionally is whether common cold remedies interact with Wegovy, which is worth reading if that is relevant to you.
Finally, the 0.25 mg starting dose is not a therapeutic dose, it exists to settle your system before the treatment dose is reached. Some impatience is normal at this stage. Worth remembering that the titration schedule is deliberate, not cautious filler.
If you are considering starting semaglutide and want to understand the full picture (eligibility, what the semaglutide medicine itself involves, and what ongoing clinical support looks like) speak to our prescribers through a free consultation. A GPhC-registered prescriber, not software, reads every submission.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.